Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Fatal Anaphylaxis to Yellow Jacket Stings in Mastocytosis: Options for Identification and Treatment of At-Risk Patients.

Vos BJPR, van Anrooij B, van Doormaal JJ, Dubois AEJ, Oude Elberink JNG.

J Allergy Clin Immunol Pract. 2017 Sep - Oct;5(5):1264-1271. doi: 10.1016/j.jaip.2017.03.019. Epub 2017 May 10.

PMID:
28499778
2.

Follow up of intima-media thickness after severe early-onset preeclampsia.

Blaauw J, Souwer ET, Coffeng SM, Smit AJ, van Doormaal JJ, Faas MM, van Pampus MG.

Acta Obstet Gynecol Scand. 2014 Dec;93(12):1309-16. doi: 10.1111/aogs.12499. Epub 2014 Sep 30.

PMID:
25200856
3.

Diminished reliability of tryptase as risk indicator of mastocytosis in older overweight subjects.

Vos BJ, van der Veer E, van Voorst Vader PC, Mulder AB, van der Heide S, Arends S, Kluin-Nelemans JC, de Monchy JG, van Doormaal JJ, Oude Elberink JN.

J Allergy Clin Immunol. 2015 Mar;135(3):792-8. doi: 10.1016/j.jaci.2014.05.047. Epub 2014 Aug 13.

PMID:
25129675
4.

Predictors of new fragility fractures after diagnosis of indolent systemic mastocytosis.

van der Veer E, Arends S, van der Hoek S, Versluijs JB, de Monchy JGR, Oude Elberink JNG, van Doormaal JJ.

J Allergy Clin Immunol. 2014 Dec;134(6):1413-1421. doi: 10.1016/j.jaci.2014.05.003. Epub 2014 Jun 27.

PMID:
24985401
5.

Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis.

Valent P, Escribano L, Broesby-Olsen S, Hartmann K, Grattan C, Brockow K, Niedoszytko M, Nedoszytko B, Oude Elberink JN, Kristensen T, Butterfield JH, Triggiani M, Alvarez-Twose I, Reiter A, Sperr WR, Sotlar K, Yavuz S, Kluin-Nelemans HC, Hermine O, Radia D, van Doormaal JJ, Gotlib J, Orfao A, Siebenhaar F, Schwartz LB, Castells M, Maurer M, Horny HP, Akin C, Metcalfe DD, Arock M; European Competence Network on Mastocytosis.

Allergy. 2014 Oct;69(10):1267-74. doi: 10.1111/all.12436. Epub 2014 May 19.

PMID:
24836395
6.

Higher mast cell load decreases the risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis.

van Anrooij B, van der Veer E, de Monchy JG, van der Heide S, Kluin-Nelemans JC, van Voorst Vader PC, van Doormaal JJ, Oude Elberink JN.

J Allergy Clin Immunol. 2013 Jul;132(1):125-30. doi: 10.1016/j.jaci.2012.12.1578. Epub 2013 Mar 14.

PMID:
23498593
7.

Prevalence of indolent systemic mastocytosis in a Dutch region.

van Doormaal JJ, Arends S, Brunekreeft KL, van der Wal VB, Sietsma J, van Voorst Vader PC, Oude Elberink JN, Kluin-Nelemans JC, van der Veer E, de Monchy JG.

J Allergy Clin Immunol. 2013 May;131(5):1429-31.e1. doi: 10.1016/j.jaci.2012.10.015. Epub 2012 Dec 6. No abstract available.

PMID:
23219169
8.

Contribution of highly sensitive diagnostic methods to the diagnosis of systemic mastocytosis in the absence of skin lesions.

Alvarez-Twose I, Matito A, Sánchez-Muñoz L, Morgado JM, Orfao A, Escribano L, van Doormaal JJ, van der Veer E, van Voorst Vader PC, Kluin PM, Mulder AB, van der Heide S, Arends S, Kluin-Nelemans JC, Oude Elberink JN, de Monchy JG.

Allergy. 2012 Sep;67(9):1190-1. doi: 10.1111/j.1398-9995.2012.02850.x. No abstract available.

PMID:
22882359
9.

Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions.

van Doormaal JJ, van der Veer E, van Voorst Vader PC, Kluin PM, Mulder AB, van der Heide S, Arends S, Kluin-Nelemans JC, Oude Elberink JN, de Monchy JG.

Allergy. 2012 May;67(5):683-90. doi: 10.1111/j.1398-9995.2012.02809.x. Epub 2012 Mar 22.

PMID:
22435702
10.

High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis.

van der Veer E, van der Goot W, de Monchy JG, Kluin-Nelemans HC, van Doormaal JJ.

Allergy. 2012 Mar;67(3):431-8. doi: 10.1111/j.1398-9995.2011.02780.x. Epub 2012 Jan 9.

PMID:
22229787
11.

Decreased arterial elasticity in formerly early-onset preeclamptic women.

Souwer ET, Blaauw J, Coffeng SM, Smit AJ, Van Doormaal JJ, Faas MM, Van Pampus MG.

Acta Obstet Gynecol Scand. 2011 Jul;90(7):797-801. doi: 10.1111/j.1600-0412.2011.01128.x. Epub 2011 May 20.

PMID:
21418159
12.

Gene expression profile, pathways, and transcriptional system regulation in indolent systemic mastocytosis.

Niedoszytko M, Oude Elberink JN, Bruinenberg M, Nedoszytko B, de Monchy JG, te Meerman GJ, Weersma RK, Mulder AB, Jassem E, van Doormaal JJ.

Allergy. 2011 Feb;66(2):229-37. doi: 10.1111/j.1398-9995.2010.02477.x. Epub 2010 Sep 7.

PMID:
21208217
13.

Gene expression analysis predicts insect venom anaphylaxis in indolent systemic mastocytosis.

Niedoszytko M, Bruinenberg M, van Doormaal JJ, de Monchy JG, Nedoszytko B, Koppelman GH, Nawijn MC, Wijmenga C, Jassem E, Elberink JN.

Allergy. 2011 May;66(5):648-57. doi: 10.1111/j.1398-9995.2010.02521.x. Epub 2010 Dec 8.

PMID:
21143240
14.

Periodontal disease and pre-eclampsia: a systematic review.

Kunnen A, van Doormaal JJ, Abbas F, Aarnoudse JG, van Pampus MG, Faas MM.

J Clin Periodontol. 2010 Dec;37(12):1075-87. doi: 10.1111/j.1600-051X.2010.01636.x. Review.

PMID:
21070324
15.

Small artery elasticity is decreased in patients with systemic lupus erythematosus without increased intima media thickness.

Nienhuis HL, de Leeuw K, Bijzet J, van Doormaal JJ, van Roon AM, Smit AJ, Graaff R, Kallenberg CG, Bijl M.

Arthritis Res Ther. 2010;12(5):R181. doi: 10.1186/ar3145. Epub 2010 Sep 28.

16.

Skin autofluorescence as marker of tissue advanced glycation end-products accumulation in formerly preeclamptic women.

Coffeng SM, Blaauw J, Souwer ET, Rakhorst G, Smit AJ, Graaff R, van Doormaal JJ, Aarnoudse JG, Faas MM, van Pampus MG.

Hypertens Pregnancy. 2011;30(2):231-42. doi: 10.3109/10641955.2010.484085. Epub 2010 Aug 11.

PMID:
20701478
17.

History of preeclampsia is not associated with an increased risk of thyroid dysfunction.

Dekker RR, Jochemsen BM, van Pampus MG, Santema JG, Roozendaal C, Groen H, Links TP, van Doormaal JJ.

Acta Obstet Gynecol Scand. 2010 Aug;89(8):1071-7. doi: 10.3109/00016349.2010.500367.

PMID:
20636245
18.

Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy.

Niedoszytko M, de Monchy J, van Doormaal JJ, Jassem E, Oude Elberink JN.

Allergy. 2009 Sep;64(9):1237-45. doi: 10.1111/j.1398-9995.2009.02118.x. Epub 2009 Jul 21. Review.

PMID:
19627278
19.

Mastocytosis in children: a protocol for management.

Heide R, Beishuizen A, De Groot H, Den Hollander JC, Van Doormaal JJ, De Monchy JG, Pasmans SG, Van Gysel D, Oranje AP; Dutch National Mastocytosis Work Group.

Pediatr Dermatol. 2008 Jul-Aug;25(4):493-500. doi: 10.1111/j.1525-1470.2008.00738.x.

PMID:
18789103
20.

Lenalidomide therapy in systemic mastocytosis.

Kluin-Nelemans HC, Ferenc V, van Doormaal JJ, van Iperen C, Peters WG, Akin C, Valent P.

Leuk Res. 2009 Mar;33(3):e19-22. doi: 10.1016/j.leukres.2008.06.013. Epub 2008 Jul 21. No abstract available.

PMID:
18644623
21.

Biochemical markers predictive for bone marrow involvement in systemic mastocytosis.

Donker ML, van Doormaal JJ, van Doormaal FF, Kluin PM, van der Veer E, de Monchy JG, Kema IP, Kluin-Nelemans HC.

Haematologica. 2008 Jan;93(1):120-3. doi: 10.3324/haematol.11558.

22.

The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress.

Mulder DJ, van Haelst PL, Wobbes MH, Gans RO, Zijlstra F, May JF, Smit AJ, Tervaert JW, van Doormaal JJ.

Cardiovasc Drugs Ther. 2007 Apr;21(2):91-7. Epub 2007 Mar 7.

23.

Women with a recent history of early-onset pre-eclampsia have a worse periodontal condition.

Kunnen A, Blaauw J, van Doormaal JJ, van Pampus MG, van der Schans CP, Aarnoudse JG, van Winkelhoff AJ, Abbas F.

J Clin Periodontol. 2007 Mar;34(3):202-7.

PMID:
17309594
24.

Skin autofluorescence, a marker of advanced glycation end products and oxidative stress, is increased in recently preeclamptic women.

Blaauw J, Smit AJ, van Pampus MG, van Doormaal JJ, Aarnoudse JG, Rakhorst G, Graaff R.

Am J Obstet Gynecol. 2006 Sep;195(3):717-22.

PMID:
16949402
25.

Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trial.

Droogendijk HJ, Kluin-Nelemans HJ, van Doormaal JJ, Oranje AP, van de Loosdrecht AA, van Daele PL.

Cancer. 2006 Jul 15;107(2):345-51.

26.

Increased intima-media thickness after early-onset preeclampsia.

Blaauw J, van Pampus MG, Van Doormaal JJ, Fokkema MR, Fidler V, Smit AJ, Aarnoudse JG.

Obstet Gynecol. 2006 Jun;107(6):1345-51.

PMID:
16738162
27.

[Lifestyle intervention for the prevention of cardiovascular disease].

Fokkema MR, Muskiet FA, van Doormaal JJ.

Ned Tijdschr Geneeskd. 2006 Mar 11;150(10):582-3. Dutch. No abstract available.

PMID:
16566425
28.

Changes in endothelial function precede the clinical disease in women in whom preeclampsia develops.

Blaauw J, Graaff R, van Pampus MG, van Doormaal JJ, Smit AJ, Rakhorst G, Aarnoudse JG.

Hypertension. 2006 Mar;47(3):e14; author reply e14-5. Epub 2006 Jan 9. No abstract available.

PMID:
16401758
29.

[Lifestyle intervention for the prevention of cardiovascular disease].

Fokkema MR, Muskiet FA, van Doormaal JJ.

Ned Tijdschr Geneeskd. 2005 Nov 19;149(47):2607-12. Review. Dutch.

PMID:
16355572
30.

Discovery and consequences of apolipoprotein-epsilon(3Groningen): a G-insertion in codon 95/96 that is predicted to cause a premature stop codon.

Dijck-Brouwer DA, van Doormaal JJ, Kema IP, Brugman AM, Kingma AW, Muskiet FA.

Ann Clin Biochem. 2005 Jul;42(Pt 4):264-8.

PMID:
15989726
31.

The European Competence Network on Mastocytosis (ECNM).

Valent P, Arock M, Bischoff SC, Bühring HJ, Brockow K, Escribano L, Födinger M, Grabbe J, Hartmann K, Henz BM, Horny HP, Kluin-Nelemans HC, Lima M, Marone G, Orfao A, Parwaresch RM, Sillaber C, Sotlar K, Sperr WR, Triggiani M, Van Doormaal JJ, Wolff K, Zuberbier T.

Wien Klin Wochenschr. 2004 Oct 30;116(19-20):647-51.

PMID:
15941072
32.

Abnormal endothelium-dependent microvascular reactivity in recently preeclamptic women.

Blaauw J, Graaff R, van Pampus MG, van Doormaal JJ, Smit AJ, Rakhorst G, Aarnoudse JG.

Obstet Gynecol. 2005 Mar;105(3):626-32.

PMID:
15738035
33.

[Clinical reasoning and decision-making in practice. A 31-year-old woman with transient monocular blindness and polycythaemia].

Houwerzijl EJ, van Haelst PL, van Doormaal JJ, Gans RO.

Ned Tijdschr Geneeskd. 2005 Jan 15;149(3):125-31. Dutch.

PMID:
15693587
34.

Cladribine therapy for systemic mastocytosis.

Kluin-Nelemans HC, Oldhoff JM, Van Doormaal JJ, Van 't Wout JW, Verhoef G, Gerrits WB, van Dobbenburgh OA, Pasmans SG, Fijnheer R.

Blood. 2003 Dec 15;102(13):4270-6. Epub 2003 Aug 21.

35.

Fasting vs nonfasting plasma homocysteine concentrations for diagnosis of hyperhomocysteinemia.

Fokkema MR, Gilissen MF, Van Doormaal JJ, Volmer M, Kema IP, Muskiet FA.

Clin Chem. 2003 May;49(5):818-21. No abstract available.

36.

Low diagnostic value of fasting and post-methionine load homocysteine tests. A study in Dutch subjects with homocysteine test indications.

Fokkema MR, Dijck-Brouwer DA, van Doormaal JJ, Reijngoud DJ, Muskiet FA.

Clin Chim Acta. 2003 May;331(1-2):153-7.

PMID:
12691876
37.

Correlates of endothelial function and their relationship with inflammation in patients with familial hypercholesterolaemia.

van Haelst PL, van Doormaal JJ, Asselbergs FW, van Roon AM, Veeger NJ, Henneman MM, Smit AJ, Tervaert JW, May JF, Gans RO.

Clin Sci (Lond). 2003 Jun;104(6):627-32.

PMID:
12558496
38.

AECA and ANCA in patients with premature atherosclerosis.

van Haelst PL, Kobold AC, van Doormaal JJ, Tervaert JW.

Int Rev Immunol. 2002 Jan-Feb;21(1):19-26.

PMID:
12187842
39.

Positive effects of a chicken eggshell powder-enriched vitamin-mineral supplement on femoral neck bone mineral density in healthy late post-menopausal Dutch women.

Schaafsma A, van Doormaal JJ, Muskiet FA, Hofstede GJ, Pakan I, van der Veer E.

Br J Nutr. 2002 Mar;87(3):267-75.

PMID:
12064336
40.

Antineutrophil cytoplasmatic antibodies in patients with premature atherosclerosis: prevalence and association with risk factors.

van Haelst PL, Asselbergs FW, van Doormaal JJ, Veeger NJ, May JF, Holvoet P, Gans RO, Tervaert JW.

J Intern Med. 2002 Jan;251(1):29-34.

41.

Secondary prevention with fluvastatin decreases levels of adhesion molecules, neopterin and C-reactive protein.

van Haelst PL, van Doormaal JJ, May JF, Gans RO, Crijns HJ, Tervaert JW.

Eur J Intern Med. 2001 Dec;12(6):503-9.

PMID:
11711273
42.

Influence of vitamin-optimized plasma homocysteine cutoff values on the prevalence of hyperhomocysteinemia in healthy adults.

Fokkema MR, Weijer JM, Dijck-Brouwer DA, van Doormaal JJ, Muskiet FA.

Clin Chem. 2001 Jun;47(6):1001-7.

43.

No long-lasting or intermittent mast cell activation in acute coronary syndromes.

van Haelst PL, Timmer JR, Crijns HJ, Kauffman HF, Gans RO, van Doormaal JJ.

Int J Cardiol. 2001 Mar;78(1):75-80.

PMID:
11259815
44.

Effects of initial and long-term lipid-lowering therapy on vascular wall characteristics.

Ubels FL, Muntinga JH, van Doormaal JJ, Reitsma WD, Smit AJ.

Atherosclerosis. 2001 Jan;154(1):155-61.

PMID:
11137095
45.

[Pregnancy in women with diabetes mellitus type I: maternal and perinatal complications, in spite of good blood glucose control].

Evers IM, Bos AM, Aalders AL, van Ballegooie E, de Valk HW, van Doormaal JJ, ter Brugge HG, Visser GH.

Ned Tijdschr Geneeskd. 2000 Apr 22;144(17):804-9. Dutch.

PMID:
10800551
46.

A frequent mutation in the lipoprotein lipase gene (D9N) deteriorates the biochemical and clinical phenotype of familial hypercholesterolemia.

Wittekoek ME, Moll E, Pimstone SN, Trip MD, Lansberg PJ, Defesche JC, van Doormaal JJ, Hayden MR, Kastelein JJ.

Arterioscler Thromb Vasc Biol. 1999 Nov;19(11):2708-13.

PMID:
10559015
47.

[Obstetric problems followed by stroke].

Lubbers MF, Aarnoudse JG, van Doormaal JJ.

Ned Tijdschr Geneeskd. 1999 Apr 3;143(14):705-8. Dutch.

PMID:
10347622
48.

Gamma-linolenic acid does not augment long-chain polyunsaturated fatty acid omega-3 status.

Brouwer DA, Hettema Y, van Doormaal JJ, Muskiet FA.

Prostaglandins Leukot Essent Fatty Acids. 1998 Nov;59(5):329-34.

PMID:
9888208
49.

Influence of fasting on circulating levels of alpha-tocopherol and beta-carotene. Effect of short-term supplementation.

Brouwer DA, Molin F, van Beusekom CM, van Doormaal JJ, Muskiet FA.

Clin Chim Acta. 1998 Oct;277(2):127-39.

PMID:
9853696
50.

Plasma folic acid cutoff value, derived from its relationship with homocyst(e)ine.

Brouwer DA, Welten HT, Reijngoud DJ, van Doormaal JJ, Muskiet FA.

Clin Chem. 1998 Jul;44(7):1545-50.

Supplemental Content

Loading ...
Support Center